Neelim للاستشارات الصحية
Neelim

Free Neurology mock test

25 original exam-style questions from our Neurology bank, timed at the exam’s own pace, scored against the 65% DHA pass mark. They span 13 of the 13 blueprint domains, so you will see exactly where you are weakest - free, no sign-up.

DHA NRO5011Pass mark DHA 65% · SCFHS 65% · QCHP 65%

Free diagnosticNo sign-up · no email · results instantly

Sit 25 original exam-style questions at real exam pace

These are 25 original questions taken from our Neurology bank, spread across 13 of the 13 domains of the published blueprint. You get 72 seconds per question, which is exactly the pace of the real NRO5011 exam (30 minutes for 25). At the end you will see which domains you are weakest in, and the full worked reasoning for every question.

25
questions
30:00
time limit
65%
DHA pass mark

A short diagnostic cannot predict whether you will pass - only the real exam does that. It will show you, honestly, where you currently stand.

Quick answer

The Neurology exam at a glance

The Neurology licensing exam is a computer-based, multiple-choice test, and each GCC regulator sets its own. DHA, SCFHS and QCHP publish exact figures, listed below. DOH licenses the title without a published written exam. This free mock gives you 25 original exam-style questions at 72 seconds each, scored against the 65% DHA pass mark, then shows your weakest domains.

Published exam figures

  • DHA

    Specialist Neurology (NRO5011)

    UAE150 MCQs3 hours

    65%

    pass mark

  • SCFHS

    Saudi Classification Examination - Neurology

    Saudi Arabia200 MCQs240 minutes

    65%

    pass mark

  • QCHP

    Specialist Neurology

    Qatar150 MCQs3 hours

    65%

    pass mark

Attempts in the UAE
3 in total across DHA, DOH, MOHAP and SHA
This free mock
25 questions · 30 minutes · 13 of 13 domains
Full bank
525+ questions · 3 to 6 papers · AED 319
Regulators
DHA, SCFHS, QCHP, DOH, MOHAP, SHA, NHRA, OMSB and Kuwait MOH

How this free Neurology mock works

25
original questions
30 min
time limit
72s
per question
13 of 13
blueprint domains
  • You get 72 seconds per question, the pace of a 150-question paper in 3 hours. The timer runs in your browser and ends the sitting when it reaches zero.
  • Your score is set against the 65% DHA pass mark, the published figure for this exam. No other number is invented: there is no percentile and no pass probability.
  • At the end you see your score, your pace per question, every domain ranked weakest first, and the worked answer and source for all 25 questions.
  • You can mark each answer “sure” or “not sure”. Wrong answers you were sure about are shown first, because they are the ones you would not stop to check in the real exam.
  • Your last result is saved in your own browser only, so you can come back and compare. Nothing is sent to us.

What the real Neurology licensing exam looks like

The Neurology exam is a computer-based multiple-choice paper, published by 3 regulators: DHA NRO5011 (pass mark 65%), SCFHS (pass mark 65%), QCHP (pass mark 65%). DOH license the title without a published written exam. Every regulator's format, pass mark and fee is in the table below; confirm yours before booking.

Pass marks at a glance: exam codes and pass marks by regulator for every written exam in one sourced table.

Before you can book the exam at all you need Dataflow primary source verification of your degree, licence and experience, which typically runs several weeks. Candidates often underestimate this and end up sitting the exam sooner after study than they planned. Check where you stand with our free eligibility checker or confirm whether your title even requires an exam using the Prometric exam checker.

You get three attempts in total across all UAE authorities, not three each, under the Unified Professional Qualification Requirements. At roughly AED 1,030 per attempt, plus the licensing delay each failure adds to your visa and start date, the cost of going in underprepared is not really the exam fee.

Neurology licensing exam in every GCC country
RegulatorExamFormatPass markFee per attempt
Specialist Neurology (NRO5011)
150 MCQs in 3 hours65%USD 280 (about AED 1,030)
SCFHS
Kingdom of Saudi Arabia
Practise →
Saudi Classification Examination - Neurology
200 MCQs in 240 minutes65%Not published
QCHP
State of Qatar
Practise →
Specialist Neurology
150 MCQs in 3 hours65%Not published
DOH
Abu Dhabi, Al Ain and Al Dhafra
Practise →
No written exam published
Oral assessment / interview, confirmed with DOH (Oct 2026); no written exam
Panel / reviewNot publishedNot published
MOHAP
Northern Emirates - Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah
Practise →
MOHAP licensing exam
Regulator-wide format
Computer-basedNot publishedNot published
SHA
Emirate of Sharjah
Practise →
SHA licensing exam
Regulator-wide format
Set at assessmentNot publishedNot published
NHRA
Kingdom of Bahrain
Practise →
NHRA licensing exam
Regulator-wide format
Prometric CBTNot publishedNot published
OMSB
Sultanate of Oman
Practise →
No exam published for this title
No OMSB exam published for this title; check with OMSB
Not publishedNot publishedNot published
Kuwait MOH
State of Kuwait
Practise →
No exam published for this title
Kuwait MOH publishes no exam for this title; check with the MOH
Not publishedNot publishedNot published

Highlighted rows publish figures for this exact Neurology exam; the others show the regulator's general rules.

What is on the Neurology exam: the full blueprint

The published blueprint splits into 13 domains and 260 testable sub-topics. For each one you can see its weight, how many questions this mock asks on it, and about how many the full bank holds.

  • Cerebrovascular Disorders15%

    20 sub-topics · 4 in this mock · about 72 in the full bank

    official - DHA/SCFHS blueprint

  • Epilepsy and Paroxysmal Disorders15%

    20 sub-topics · 3 in this mock · about 72 in the full bank

    official - DHA/SCFHS blueprint

  • Cephalgia and Headache Disorders15%

    20 sub-topics · 3 in this mock · about 72 in the full bank

    official - DHA/SCFHS blueprint

  • Neuromuscular Disorders7%

    20 sub-topics · 1 in this mock · about 34 in the full bank

    official - DHA/SCFHS blueprint

  • Neuro-Immunological and Demyelinating Disorders7%

    20 sub-topics · 1 in this mock · about 34 in the full bank

    official - DHA/SCFHS blueprint

  • Neuro-Infectious Disorders7%

    20 sub-topics · 1 in this mock · about 34 in the full bank

    official - DHA/SCFHS blueprint

  • Movement Disorders7%

    20 sub-topics · 2 in this mock · about 34 in the full bank

    official - DHA/SCFHS blueprint

  • Cognitive Disorders7%

    20 sub-topics · 3 in this mock · about 34 in the full bank

    official - DHA/SCFHS blueprint

  • Clinical Neurophysiology, Neuroanatomical Localization and Neuroimaging5%

    20 sub-topics · 3 in this mock · about 24 in the full bank

    official - DHA/SCFHS blueprint; localization/imaging content is examined throughout, per the Brazis 'Localization in Clinical Neurology' reference

  • Neurology of Systemic Diseases (including Nutritional, Metabolic and Toxic)5%

    20 sub-topics · 1 in this mock · about 24 in the full bank

    official - DHA/SCFHS blueprint; footnoted as including nutrition, metabolic, etc.

  • Neuro-oncology, Neuro-ophthalmology, Neuro-otology and Sleep Neurology~8%

    20 sub-topics · 1 in this mock · about 39 in the full bank

    est.; not a separate section in the official DHA/SCFHS blueprint - this content is assessed within the Cognitive, Movement, Systemic Diseases and Clinical Neurophysiology sections, but is commonly examined and must not be omitted

  • Patient Safety and Quality in Neurological Care5%

    20 sub-topics · 1 in this mock · about 24 in the full bank

    official - DHA/SCFHS blueprint; reference: SCFHS 'Essentials of Patient Safety'

  • Professionalism, Ethics and Communication5%

    20 sub-topics · 1 in this mock · about 24 in the full bank

    official - DHA/SCFHS blueprint; reference: SCFHS 'Professionalism and Ethics, Handbook for Residents'

Bank counts are estimates from the published weights the bank is written to, rounded.

This mock samples 13 of 13 domains. The full bank covers all 13 across 525+ questions.

See the full bank - AED 319

How to use your mock score

These bands are set against the 65% DHA pass mark and match the verdict on your result screen. On 25 questions, a score near the pass mark has a 95% margin of error of about ±19 points, so treat the band as a direction, not a forecast.

Below 60%

Below the line

On this sample you would likely fall short of the 65% pass mark today. Do not book yet. Start with your two weakest domains from the result, then sit full-length papers until you clear the line with room to spare.

60% to 74%

Close to the line

A few questions decide it. On a 175-question paper, every 1% is one or two questions, so drill your weakest domains and build a margin on timed papers before you book.

75% and above

On track

Clear of the pass mark on this sample. 25 questions is a small sample, so confirm it over full-length timed papers before you book: stamina and pacing fail candidates who know the material.

Getting an honest score

  1. 1Sit it cold, once. Do not look anything up. A diagnostic you help yourself through tells you nothing. The number you get is only useful if it is honest.
  2. 2Read every rationale, especially the ones you got right. Getting a question right by elimination is not the same as knowing it. The worked reasoning is free, whether or not you buy anything.
  3. 3Work on your weakest domain first. The breakdown orders your domains worst first for exactly this reason. Studying what you are already good at feels productive and moves nothing.
  4. 4Re-sit under full exam conditions later. The real paper is much longer than 25 questions and stamina matters. The full bank's 3 to 6 papers are written for exactly this.

A worked Neurology exam question

Every question in the mock and in the paid bank is written to this standard: a clinical stem, four plausible options and the reasoning for the answer, with its source.

Cognitive Disorders

Which single clinical feature best distinguishes delirium from an established dementia?

  1. AImpairment of episodic memory
  2. BAcute onset with a fluctuating disturbance of attention and awarenessCorrect
  3. CThe presence of visual hallucinations
  4. DImpaired confrontation naming

Why: The DSM-5 core of delirium is an acute (hours to days) disturbance of attention and awareness that fluctuates in severity over the course of the day, usually with an identifiable medical precipitant. Episodic memory impairment and naming difficulty occur in both conditions and are not discriminating, and visual hallucinations are common in delirium but also characterise dementia with Lewy bodies. Attention is the domain to test at the bedside (digit span, months backwards) when delirium is suspected.

Source: DSM-5-TR (American Psychiatric Association, 2022); NICE clinical guideline CG103, Delirium: prevention, diagnosis and management (updated 2023)

Neurology sample questions with answers

10 more original exam-style Neurology questions, worked in full. They are not real or recalled exam questions, and none of them is in the mock above or on the bank page, so sit the mock first if you have not.

  1. Question 1 · Epilepsy and Paroxysmal Disorders

    A 47-year-old man has a first unprovoked generalised tonic-clonic seizure. He sustained a severe traumatic brain injury 6 years ago; MRI now shows right frontal encephalomalacia and gliosis, and his routine EEG demonstrates right frontal sharp waves. He is otherwise well and works as a schoolteacher. What is the most appropriate management?

    1. AWithhold antiseizure medication and review in 12 months, as a single seizure does not define epilepsy
    2. BRepeat the EEG after sleep deprivation before making any treatment decision
    3. CStart an antiseizure medication now, because his recurrence risk is high enough to diagnose epilepsy after one seizure
    4. DStart an antiseizure medication only if a second seizure occurs within the next 6 months
    Show answer and explanation

    Correct answer: C. Start an antiseizure medication now, because his recurrence risk is high enough to diagnose epilepsy after one seizure

    The ILAE definition allows a diagnosis of epilepsy after one unprovoked seizure when the risk of further seizures over 10 years is at least 60%, comparable to the risk after two unprovoked seizures. A remote symptomatic lesion plus epileptiform discharges places this man well above that threshold, so treatment is indicated now rather than deferred. A repeat sleep-deprived EEG will not change management when epileptiform activity is already documented, and waiting for a second seizure exposes him to avoidable injury and driving restriction.

    Reference: Fisher RS et al., ILAE practical clinical definition of epilepsy, Epilepsia 2014; NICE NG217 Epilepsies in children, young people and adults, 2022

  2. Question 2 · Neuro-oncology, Neuro-ophthalmology, Neuro-otology and Sleep Neurology

    A 47-year-old woman develops seizures with olfactory auras. Perimetry shows a left superior homonymous quadrantanopia that is incongruous between the two eyes. Which structure is most likely involved?

    1. ARight temporal lobe optic radiation (Meyer loop)
    2. BRight parietal optic radiation (dorsal fibres)
    3. CLeft lateral geniculate nucleus
    4. DRight optic nerve
    Show answer and explanation

    Correct answer: A. Right temporal lobe optic radiation (Meyer loop)

    Inferior retinal fibres, which carry the superior visual field, sweep anteriorly around the temporal horn as Meyer loop, so a right temporal lesion produces a contralateral superior quadrantanopia, classically incongruous and accompanied by temporal-lobe seizure phenomena such as olfactory auras. Dorsal parietal radiation lesions cause an inferior quadrantanopia ('pie on the floor'). A left geniculate lesion would cause a right-sided defect, and an optic nerve lesion causes monocular loss with a relative afferent pupillary defect.

    Reference: Brazis, Masdeu & Biller, Localization in Clinical Neurology, 7th ed. (2021); AAN Continuum: Neuro-ophthalmology

  3. Question 3 · Neuro-Immunological and Demyelinating Disorders

    A 52-year-old hypertensive smoker is referred with multiple T2 white matter hyperintensities found on MRI and possible demyelination. Which single imaging finding would most strongly support multiple sclerosis rather than chronic small-vessel ischaemic disease?

    1. AConfluent periventricular caps around the frontal horns
    2. BScattered punctate lesions in the deep white matter of the centrum semiovale
    3. CT2 hyperintensities involving the basal ganglia and thalami
    4. DA single vein running through the centre of the majority of the lesions on susceptibility-weighted imaging
    Show answer and explanation

    Correct answer: D. A single vein running through the centre of the majority of the lesions on susceptibility-weighted imaging

    The central vein sign reflects the perivenular inflammatory pathology of MS and is present in a high proportion of MS lesions but in relatively few microangiopathic, migrainous or NMOSD lesions; a threshold of about 40% of lesions (or the simplified 'rule of six') gives good discrimination. Periventricular caps, punctate deep white matter lesions and basal ganglia hyperintensities are all common in small-vessel disease and are non-specific.

    Reference: Sati P et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a NAIMS consensus statement. Nature Reviews Neurology 2016

  4. Question 4 · Movement Disorders

    A 69-year-old man with clearly levodopa-responsive Parkinson disease has disabling peak-dose dyskinesia and motor fluctuations. Neuropsychological testing shows mild executive dysfunction without dementia, and he has a history of recurrent depression currently in remission. Both subthalamic and pallidal targets are technically feasible. Which option is most appropriate?

    1. ASubthalamic nucleus stimulation, because it abolishes dyskinesia without any change in medication
    2. BSubthalamic nucleus stimulation, because cognitive and mood adverse effects are less frequent than with pallidal stimulation
    3. CDeep brain stimulation is absolutely contraindicated by the mild executive dysfunction
    4. DGlobus pallidus internus stimulation, because it has a direct antidyskinetic effect and carries a lower risk of cognitive and neuropsychiatric adverse effects than the subthalamic target
    Show answer and explanation

    Correct answer: D. Globus pallidus internus stimulation, because it has a direct antidyskinetic effect and carries a lower risk of cognitive and neuropsychiatric adverse effects than the subthalamic target

    Both targets give comparable motor benefit, but subthalamic stimulation permits greater dopaminergic dose reduction at the cost of more frequent cognitive decline, depression, apathy and impulsivity, whereas pallidal stimulation has a direct antidyskinetic effect and a more favourable neuropsychiatric profile, making it preferable when dyskinesia dominates and there are cognitive or mood concerns. Subthalamic stimulation reduces dyskinesia mainly through medication reduction rather than directly, and mild executive dysfunction without dementia is a relative rather than absolute contraindication.

    Reference: Odekerken VJJ et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study). Lancet Neurology, 2013; Follett KA et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. New England Journal of Medicine, 2010

  5. Question 5 · Clinical Neurophysiology, Neuroanatomical Localization and Neuroimaging

    A 22-year-old woman with recurrent syncope has an EEG showing bursts of sharply contoured 6 Hz activity over the midtemporal regions occurring only in drowsiness, running for 1-2 seconds, with no after-going slow wave and no disruption of the background. Which is the most appropriate interpretation?

    1. AFocal interictal epileptiform discharges supporting temporal lobe epilepsy
    2. BTemporal intermittent rhythmic delta activity
    3. CElectrographic seizure activity
    4. DRhythmic midtemporal theta of drowsiness, a benign normal variant
    Show answer and explanation

    Correct answer: D. Rhythmic midtemporal theta of drowsiness, a benign normal variant

    Rhythmic midtemporal theta of drowsiness (psychomotor variant) is a benign pattern of sharply contoured or notched 5-7 Hz rhythms confined to drowsiness, without evolution, after-going slow waves or background disruption, and it has no epileptogenic significance. True interictal discharges disrupt the background and are usually followed by a slow wave. Electrographic seizures evolve in frequency, morphology and field, and TIRDA is a delta-frequency pattern.

    Reference: Ebersole & Pedley, Current Practice of Clinical Electroencephalography, 4th ed. (2014); Tatum, Handbook of EEG Interpretation, 3rd ed. (2021)

  6. Question 6 · Patient Safety and Quality in Neurological Care

    A 68-year-old man taking dabigatran, with his last dose four hours ago, develops an expanding traumatic subdural haematoma requiring urgent evacuation. Which intervention provides the most rapid and specific reversal?

    1. AAndexanet alfa by bolus and infusion
    2. BIdarucizumab 5 g intravenously
    3. CFour-factor prothrombin complex concentrate 50 units/kg
    4. DUrgent haemodialysis before transfer to theatre
    Show answer and explanation

    Correct answer: B. Idarucizumab 5 g intravenously

    Idarucizumab is the licensed specific monoclonal antibody fragment reversal agent for dabigatran and normalises dilute thrombin time within minutes. Andexanet alfa reverses factor Xa inhibitors such as apixaban and rivaroxaban, not dabigatran. Prothrombin complex concentrate is only a non-specific fallback if idarucizumab is unavailable, and although dabigatran is dialysable, haemodialysis is far too slow and impractical for a patient needing immediate craniotomy.

    Reference: ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants (2020); RE-VERSE AD trial, NEJM 2017

  7. Question 7 · Cerebrovascular Disorders

    In the CREST trial comparing carotid endarterectomy with carotid artery stenting, which periprocedural pattern was observed?

    1. AStenting had fewer strokes but more myocardial infarctions than endarterectomy
    2. BStenting had a higher periprocedural stroke rate, whereas endarterectomy had a higher periprocedural myocardial infarction rate
    3. CBoth stroke and myocardial infarction were more frequent after stenting
    4. DThere was no difference in any individual outcome between the two procedures
    Show answer and explanation

    Correct answer: B. Stenting had a higher periprocedural stroke rate, whereas endarterectomy had a higher periprocedural myocardial infarction rate

    CREST found similar composite outcomes but a clear divergence in components: periprocedural stroke was more common with stenting, particularly in patients over about 70, while periprocedural myocardial infarction was more common with endarterectomy. This drives the practice of favouring endarterectomy in older patients with suitable anatomy and reserving stenting for those with hostile necks, restenosis or high surgical cardiac risk.

    Reference: Brott et al., CREST, NEJM 2010

  8. Question 8 · Cephalgia and Headache Disorders

    A 70-year-old man with biopsy-proven giant cell arteritis has relapsed twice during prednisolone tapering and has developed steroid-induced hyperglycaemia and vertebral osteopenia. Which additional agent has randomised trial evidence for sustained remission and steroid sparing in giant cell arteritis?

    1. ARituximab
    2. BInfliximab
    3. CTocilizumab
    4. DHydroxychloroquine
    Show answer and explanation

    Correct answer: C. Tocilizumab

    The GiACTA trial showed that tocilizumab, an interleukin-6 receptor antagonist, achieves significantly higher sustained steroid-free remission rates and lowers cumulative corticosteroid exposure in giant cell arteritis, and it is recommended for relapsing disease or where steroid toxicity is a concern (noting that it suppresses CRP and ESR, so relapse must be judged clinically). Methotrexate has more modest evidence; rituximab, infliximab and hydroxychloroquine have not shown benefit in giant cell arteritis trials.

    Reference: Stone JH et al. Trial of Tocilizumab in Giant-Cell Arteritis (GiACTA). New England Journal of Medicine, 2017; ACR/VF Guideline 2021

  9. Question 9 · Neuromuscular Disorders

    A 58-year-old woman treated 6 years ago with mastectomy and axillary radiotherapy for breast cancer develops slowly progressive numbness and weakness of the right arm over 12 months. Which combination of features most strongly favours radiation-induced brachial plexopathy rather than neoplastic infiltration of the plexus?

    1. ASevere early pain, lower trunk predominance and an ipsilateral Horner syndrome
    2. BRapidly progressive hand wasting with a supraclavicular mass
    3. CRelatively painless upper trunk weakness with lymphoedema and myokymic discharges on needle EMG
    4. DAcute onset with fever and raised inflammatory markers
    Show answer and explanation

    Correct answer: C. Relatively painless upper trunk weakness with lymphoedema and myokymic discharges on needle EMG

    Radiation plexopathy characteristically presents with paraesthesiae and relatively painless weakness in an upper trunk (C5-C6) distribution, often with arm lymphoedema and skin changes, and needle EMG shows myokymic discharges, a highly specific marker of radiation injury. Neoplastic plexopathy typically causes severe early pain, lower trunk (C8-T1) involvement and Horner syndrome, often with a palpable mass. Acute febrile presentations suggest infection rather than either diagnosis.

    Reference: Bradley and Daroff's Neurology in Clinical Practice, 8th edition (2022), plexopathy chapter; Jaeckle KA, Seminars in Neurology (2010), Neurologic manifestations of neoplastic and radiation-induced plexopathies

  10. Question 10 · Neuro-Infectious Disorders

    The same patient's diagnosis of invasive meningococcal disease is confirmed. A neurology resident performed bag-mask ventilation without a mask during intubation, and the patient's flatmates are asking for advice. Which action is correct?

    1. ANo chemoprophylaxis is needed for anyone, because the patient has already received antibiotics
    2. BChemoprophylaxis should be offered to all ward staff who entered the room, but the case need not be notified
    3. CNotify the public health authority urgently as a notifiable disease, and offer chemoprophylaxis (for example ciprofloxacin, rifampicin or ceftriaxone) to household or equivalent close contacts and to the healthcare worker with direct unprotected exposure to respiratory secretions
    4. DOffer only vaccination to close contacts, as chemoprophylaxis is ineffective
    Show answer and explanation

    Correct answer: C. Notify the public health authority urgently as a notifiable disease, and offer chemoprophylaxis (for example ciprofloxacin, rifampicin or ceftriaxone) to household or equivalent close contacts and to the healthcare worker with direct unprotected exposure to respiratory secretions

    Invasive meningococcal disease is a statutorily notifiable condition in GCC states and internationally, and prompt notification allows public health contact tracing. Chemoprophylaxis is indicated for household and equivalent close contacts and for healthcare workers with direct unprotected exposure to respiratory secretions, such as during airway management, ideally within 24 hours. Casual ward contact does not warrant prophylaxis, treatment of the index case does not protect contacts, and vaccination is a complementary measure for certain serogroups but does not replace prompt chemoprophylaxis.

    Reference: CDC Meningococcal Disease chemoprophylaxis recommendations, MMWR ACIP (2020); WHO meningitis outbreak response guidance

Last reviewed September 2026. About these questions: every item is original, written to the published blueprint, with a rationale and a reference, and no recalled or leaked exam content is used. How we write our questions.

Free mock vs the full Neurology bank

The mock tells you where you stand. The bank is how you close the gap.

Free Neurology mock compared with the full bank
What you getFree mockFull bank
Questions25525+
Papers1 short timed set3 to 6 full-length papers, about 175 each
Blueprint coverage13 of 13 domainsAll 13 domains, 260 sub-topics
Worked rationaleEvery questionEvery question
ReferenceEvery questionEvery question
Timing30 minutes in your browserExam-length papers to sit against the clock
FormatOnline, freePDF sent to you, yours to keep
PriceFreeAED 319, paid once

Full Neurology bank

Close your gaps before exam day

  • 525+ original questions in 3 to 6 full-length papers
  • A worked rationale and a reference on every question
  • Prepared for your regulator's blueprint and pass mark

One-time price

AED 319

About a third of one exam fee (about AED 1,030 per attempt)

Unlock the full bank →

No subscription · yours to keep

Frequently asked questions

Is this Neurology mock test really free?
Yes. All 25 questions, your score, the domain breakdown and the full worked answers are free, with no sign-up, no email and no payment. The paid Neurology bank is a separate, much larger set of 525+ questions across 3 to 6 papers at AED 319.
Are these real Neurology exam questions?
No. They are original questions written to the published Neurology blueprint and drawn from our full bank, not leaked or recalled items. Recalled questions breach exam security rules and are often out of date. These follow the exam's format and domain weighting.
What is the pass mark for the Neurology exam?
By regulator: DHA NRO5011 (pass mark 65%), SCFHS (pass mark 65%), QCHP (pass mark 65%), each from the regulator's own exam documents. Regulators not listed publish no figure for this exam, so confirm yours before booking. Most report only pass or fail and never release your score, which is why a diagnostic like this is useful.
How long is the Neurology exam and how many questions?
DHA: 150 MCQs in 3 hours; SCFHS: 200 MCQs in 240 minutes; QCHP: 150 MCQs in 3 hours, from each regulator's own exam documents (DHA's time includes registration and the introduction, per the DHA CBT Guideline, Sep 2026). Regulators not listed publish no length for this exam, so confirm theirs in the current candidate bulletin.
What topics does the Neurology exam cover?
The published blueprint has 13 domains and 260 testable sub-topics. The heaviest are Cerebrovascular Disorders (15%), Epilepsy and Paroxysmal Disorders (15%) and Cephalgia and Headache Disorders (15%). The full domain list with weights is on this page.
How is the full Neurology bank different from this mock?
This mock is 25 questions across 13 of the 13 blueprint domains, enough to rank your domains. The full bank is 525+ questions in 3 to 6 full-length papers of about 175 questions, covering every domain, with about 72 questions on Cerebrovascular Disorders alone. Every question has a worked rationale and a reference. It costs AED 319, paid once.
What score should I aim for on this Neurology mock?
Aim for at least 75%, which is 10 points over the 65% DHA pass mark. Below 60% you would likely fall short today; between 60% and 74% a few questions decide it. On 25 questions a score near the pass mark has a margin of error of about ±19 points, so read it as a direction.
Does passing this mock mean I will pass the real exam?
No, and we will not claim otherwise. 25 questions cannot predict a full-length paper: the margin of error is about ±19 points. What it does reliably show is which blueprint domains you are weakest in, so you know where to start.
Which regulators is this Neurology mock for?
It is written to the shared Neurology blueprint, so it fits DHA, SCFHS, QCHP, DOH, MOHAP, SHA, NHRA, OMSB and Kuwait MOH. DHA, SCFHS and QCHP publish an exam for this exact title. What changes by regulator is the length, the pass mark and the local regulation questions.
How many attempts do I get at the real exam?
In the UAE, three in total across DHA, DOH, MOHAP and SHA under the Unified Professional Qualification Requirements, not three per authority. Each attempt costs roughly AED 1,030, which is why it pays to find your weak domains first.

Other free mock exams in medicine

From a 25-question mock to the full Neurology bank

525+ original questions in 3 to 6 full-length papers, each with a worked rationale and a reference, written to the same blueprint as the free mock on this page. One price: AED 319.